Vidox Consulting S.A.
We know how to make CRO business in Russia, Poland, Czech Republic, Hungary and all over Central and Eastern Europe!
Central and Eastern Europe (CEE)
C&E Europe - attractive location for Clinical & Marketing Research
- 29 countries with varying degrees of political and economic stability
- "established" and "emerging" countries
- 20 % of all clinical trials conducted globally are conducted in CEE
- Developed clinical research base
- 25 - 90 % of patients in European trials originate from CEE
- ICH-GCP is standard for CEE Regulatory Institutions and is a law in most counties
- Europe is the second largest pharmaceutical market
- Sales - approximately 100 billion US$
- CEE: rapidly growing market with a great potential (>300 M population, Europe - 380, US - 285)
Health Care in C&E Europe
- Health care system still centralised
- Large specialised medical centers
- Access to large patient populations
- Comparable medical practice and standards
- Shorter life expectancy, higher morbidity, mortality
Pharmaceutical Environment in C&EE
- Good knowledge of ICH GCP/GMP
- Investigators: qualified, enthusiastic, motivated
- Investigational sites: specialised hospitals with access to large patient pool
- Patients: motivated, compliant
- Health care environment/legislation
- Timelines
- Logistics & infrastructure
- Quality: „comparable - if not better"
- Cost: lower
VIDOX is a premier medical marketing consultancy and CRO agency providing pharmaceutical companies with strategic and tactical services from our bases in the EU and in CIS.
VIDOX promise to understand what makes your challenges unique - then to develop specific solutions based on our extensive marketing and clinical expertise.